Dr Reddy's allots shares worth Rs 83,330 to employees as stock options

Dr Reddy's allots shares worth Rs 83,330 to employees as stock options

The total issued shares moved to 16,65,44,742 and the total issued share capital increased to Rs 83,27,23,710.

FPJ Web DeskUpdated: Sunday, June 04, 2023, 01:21 PM IST
article-image
Dr Reddy's allots shares worth Rs 83,330 to employees as stock options | Image: Dr. Reddy's (Representative)

Dr. Reddy's Laboratories Limited on Saturday allotted 16,666 worth Rs 83,330 to employees as stock options, the company announced through an exchange filing. The shares of Rs 5 each were divided into two different schemes.

15,562 equity shares were allocated under the Dr. Reddy's Employee Stock Option Scheme 2002 and 1,104 shares each underlying 1,104 ADRs to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.

The total issued shares moved to 16,65,44,742 and the total issued share capital increased to Rs 83,27,23,710.

Dr. Reddy's shares

The shares of Dr. Reddy's Laboratories on Friday closed at Rs 4,618, up by 1.45 per cent.

(To receive our E-paper on WhatsApp daily, please click here.  To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

Vaibhav Global Allots 42,717 Equity Shares Under ESOP

Vaibhav Global Allots 42,717 Equity Shares Under ESOP

Asian Development Bank Appoints Bhargav Dasgupta As Vice-President For Market Solutions

Asian Development Bank Appoints Bhargav Dasgupta As Vice-President For Market Solutions

NCC Limited And J. Kumar Infra Projects Secures ₹6,301.08 Cr Contract From BMC

NCC Limited And J. Kumar Infra Projects Secures ₹6,301.08 Cr Contract From BMC

IFC, Sunteck Realty Join Hands For Investing Up To ₹7,500 Million To Expand Green Urban Housing In...

IFC, Sunteck Realty Join Hands For Investing Up To ₹7,500 Million To Expand Green Urban Housing In...

Glenmark Pharma Shares Fall Over 6% After The Sale Of 75% Stake To Nirma In Share Purchase Agreement

Glenmark Pharma Shares Fall Over 6% After The Sale Of 75% Stake To Nirma In Share Purchase Agreement